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ABSTRACT 
Background: Australia has recently introduced a new screening program for cervical cancer. There 
has also been a decline in participation rates for cervical screening.  
Aim: To complete a systematic literature review of the factors that prevent Australian women from 
participating in cervical screening.  
Methods: Authors searched CINAHL, Medline, SCOPUS and the Cochrane Library to obtain articles 
discussing Australian women’s self-identified barriers to cervical screening. Quantitative studies 
published in peer-reviewed journals after 1991 were considered. PROSPERO Registration Number: 
CRD42018105028. 
Results: The final search produced 1749 studies, with 13 quantitative papers included in the 
narrative synthesis after screening by two independent reviewers. No articles were excluded due to 
bias.  
Discussion: Self-identified barriers to screening were categorised into personal, practitioner, test-
related and logistical factors. The most commonly stated barriers included lack of time, 
embarrassment, fear of results, irrelevance and male health professionals. The use of HPV triage in 
cervical screening was not a barrier to screening however, some women regarded self-collected HPV 
testing as a barrier. Barriers to self-collection included desire for the general practitioner to 
complete the test, fear of doing the test incorrectly, wishing to include it in a general check-up and 
concerns about the test itself. 
Conclusion: A variety of personal, practitioner, test-related and logistical barriers negatively impact 
the screening participation of Australian women. Further research into barriers in the Australian 
population, and women’s attitudes towards HPV testing and self-collection is required to create 










Cervical cancer is a devastating but highly preventable disease for which timely screening is of vital 
importance. Australia’s National Cervical Cancer Screening Program (NCSP) was introduced in 1991 
and cervical cancer mortality in Australia has halved since its implementation. Between 2015 and 
2016 the NCSP cost the government $55.5 million, proving more expensive than bowel or breast 
cancer screening programs. In spite of the importance of screening for this highly preventable 
cancer, only 56.0% of eligible Australian women were screened for cervical cancer between 2015-
2016, which was less than the 58.1% screened in 2012-2013.1 This is also lower than the average 
Organisation for Economic Co-operation and Development (OECD) reported screening rate of 61.6% 
in 2013, and substantially lower than highly screened countries such as the United States at 84.5%. 
Screening programs are in fact, an indicator of national health quality of care in the OECD Health 
Indicators and are a marker of national progress in health care.2 Previous research has shown that 
the populations that are less likely to participate in screening include women from low 
socioeconomic backgrounds, rural areas, migrant backgrounds and Aboriginal and Torres Strait 
Islander heritage.1,3  
From 1st December 2017, the Australian Government implemented a new NCSP and replaced the 
biannual Pap test with a five yearly Cervical Screening Test. Women are now screened for cervical 
cancer every five years from the age of 25 to 74 years with partial HPV genotyping and a reflex liquid 
based-cytology. Never-screened or under-screened women over 30 years of age will also be offered 
a self-collected vaginal sample for HPV.1 The new NCSP provides an opportunity to discuss the 
decline in cervical screening rates in Australia.   
Understanding barriers to screening participation is crucial if increasing compliance with screening 
participation is to be achieved. Previous literature reviews have assessed barriers to cervical 
screening by country, specific sub-populations or using purely qualitative studies. These reviews 
identified a variety of personal, cultural and institutional factors that prevented women from 
participating in cervical screening.4-7 A literature review on cervical screening in countries with a 
national screening program, categorised barriers into two themes: the decision process behind 
participating in screening and any negative connotations associated with screening. Barriers that 
impacted a woman’s decision-making process included believing screening to be irrelevant and 
being unsure of its value. The procedure, emotional experiences, practitioner-related factors, fear of 
the test or fear of a positive result caused women to have negative associations with screening.6 
Previous literature reviews also concentrated on screening barriers of migrant women.8-10 Johnson 
et al. identified barriers in migrant women including fatalistic attitudes towards screening, lack of 
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knowledge, feeling well and threat to virginity.10 To our knowledge there are no completed or on-
going literature reviews that synthesise barriers to cervical cancer screening in an Australian context.  
Identifying barriers to screening will facilitate an understanding of why participation in cervical 
screening is decreasing in Australian women and assist in the creation of evidence-based 
interventions to reverse this trend. Subsequently, this review aims to ascertain the self-identified 
barriers that prevent Australian women from participating in cervical screening. It will assess 
quantitative studies that discuss what Australian women who are eligible for screening, under both 
versions of the NCSP, identify as barriers for cervical cancer screening. It will also present the cervical 
screening rates of women in the included studies. This is a timely study given the recent introduction 
of the new screening guidelines and will synthesise the why women decline to participate in this 
potentially life-saving screening program.  
 
METHODS 
This study protocol was prospectively registered with PROSPERO (Registration Number: 
CRD42018105028) and reported according to the ‘Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses’ (PRISMA) guidelines.11   
ELIGIBILITY CRITIERA  
Reviewers determined selection criteria to assess the appropriateness of articles for inclusion in this 
review. Quantitative peer-reviewed articles written in English and published after the introduction of 
the original NCSP in 1991 were considered. Inclusion criteria included: discussion of firm barriers to 
cervical screening; barriers must be directly identified by Australian women and articles must be 
written in the context of the Australian NCSP (old or new). A ‘barrier’ was defined as a belief that 
would actively prevent an Australian woman from participating in cervical screening. Reviewers 
excluded articles related to the results of interventions to improve cervical cancer screening and any 
barriers identified through purely statistical analysis. Previous hysterectomy or no prior sexual 
activity were omitted as barriers, as under NCSP guidelines it is not appropriate to screen these 
women. Systematic reviews, letters, case reports and purely qualitative studies were excluded. 
INFORMATION SOURCES  
A comprehensive search was conducted of quantitative studies published on MEDLINE (Ovid), 
CINAHL, Scopus and the Cochrane Library on 15th May 2018. The final search of these databases was 
conducted on 27th July 2018. Additional articles were also identified by perusing the reference lists of 




Articles from SCOPUS and Cochrane Library were searched using key words, Boolean Operators and 
truncations. MEDLINE (Ovid) and CINAHL were searched using these methods in conjunction with 
the appropriate MeSH headings. Search terms included keywords for cervical screening (e.g. pap 
test), attitudes (e.g. opinions) and Australian location (e.g. Sydney OR Aust*). This search was 
conducted in assistance with a medical librarian. Full search details are outlined in Appendix 1. 
STUDY SELECTION  
Search results were imported into EndNote and duplicates were removed. Titles and abstracts were 
screened by two independent reviewers (A.N. and H.B.) to identify articles that may meet the 
inclusion criteria. These reviewers then independently assessed the full texts of these articles using 
the pre-determined selection criteria and any disagreements regarding the eligibility of studies were 
discussed with a third reviewer (J.B.).  
DATA COLLECTION  
Data was extracted by two authors (A.N. and H.B.) and tabulated. The reviewers developed a 
standardised extraction protocol that included study population, study methodology, recruitment 
strategy, participant numbers and completion rates. Reviewers also extracted barriers to screening 
and the calculated screening participation rate. Authors were contacted for further data when 
necessary.  
RISK OF BIAS 
The included studies were assessed using a modified version of National Heart, Lung and Blood 
Institute Quality Assessment Tool for observational studies.12 Each criterion was allocated equal 
weighting and these studies were then graded as good, fair or poor. Any studies found to be of poor 
quality were interpreted with caution.  
SUMMARY MEASURES 
The principal summary measure was the proportion of women who identified a specific factor as a 
firm barrier to screening. If available, barriers were presented by screening status (e.g. well-
screened, under-screened, never-screened). Results were presented with statistical significance 
where possible.   
Authors were unable to complete a meta-analysis due to the heterogeneity of the data and the lack 




The final search across MEDLINE (Ovid), CINAHL, Scopus and Cochrane Library produced 1743 
articles (Fig. 1). After duplicates were removed, 1491 papers were screened based on title and 
abstract. Forty-nine full texts were assessed for eligibility and thirty-two articles were excluded as 
they did not meet the pre-determined inclusion criteria. Two articles were excluded as a copy of 
their full text could not be obtained. A further two articles were excluded after discussion with the 
third-party reviewer (J.B.). Six articles were identified from perusing reference lists from the included 
articles and excluded review articles. These six articles were excluded per the inclusion criteria. A 
total of 13 studies were included in this review.  
Figure 1: PRISMA Flow Chart  
STUDY CHARACTERISTICS  
The included articles all utilised cross-sectional surveys for their study methodology. Dieng et al. and 
Sultana et al. surveyed women from the general Australian population. The remaining studies 
concentrated on the following subgroups of the population: women who have sex with women 
(WSW)13, migrant women14-17, older women18, bone marrow transplant (BMT) survivors19, rurality20 
and women with a history of mental illness21 or sexual assault22. (Table 1) 
Table 1: Study characteristics table 
RISK OF BIAS 
Using the Quality Assessment Tool, five studies were found to be good quality and eight studies 
were found to be fair quality. No studies were deemed to be of poor quality. (Table 2) 
Table 2: Quality Assessment Tool 
RESULTS OF INDIVIDUAL STUDIES 
Table 3: Results Table (Barriers to Cervical Screening)  
Personal Barriers  
Seven of the thirteen studies reported that women’s personal beliefs prevented participation in 
regular cervical screening. Identified personal beliefs included: perceiving screening to be irrelevant, 
a lack of knowledge about screening, fear of the test and fear of results. 13,15,16,18-20,23  
Five studies reported that women believed cervical screening was irrelevant to them.15,16,19,20,23 Two 
studies stated that migrant women believed screening to be unnecessary.15,16 Thai immigrants 
believed screening was unnecessary in unmarried women,16 while women from former Yugoslavia 
believed screening was unnecessary in an absence of symptoms, due to age and having had only one 
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sexual partner15. A study of women who have had a previous allogenic BMT reported their belief 
that they did not require regular cervical screening.19 
A lack of knowledge about screening was identified as another barrier to participation in cervical 
screening in three studies.13,16,23 Sultana et al. reported that under-screened women were unsure 
when they required screening,23 while Thai migrants described that they were unsure of benefits of 
screening and were unsure how to participate16.  
Three studies described fear of an abnormal result as a barrier to cervical screening.15,16,18 Migrants 
from former Yugoslavia15 and Thailand16 identified that fear of cancer prevented them from 
participating in screening. Under-screened women between 40 to 70 years of age were reported to 
have identified fear of the result as preventing them from participating in screening. This barrier was 
less prevalent in well-screened older women.18  
Feeling well was identified by two studies as another contributing barrier to cervical screening 
participation.16,20 Girgis et al. identified across under-screened women in urban, rural and remote 
regions.20 It was also identified as a barrier by Thai migrant women.16 
Practitioner Barriers 
The health professional performing the test were identified by nine of the fourteen studies as a 
possible barrier to screening. Barriers included comfort level with the practitioner and preferences 
for gender or language.13,15-17,19-21,23 Selecting the correct practitioner was deemed a barrier by 
under-screened WSW13 and women from former Yugoslavia15.  
Male health professionals were found to affect women’s participation in cervical screening across 
five of the thirteen studies.15-17,20,21 One paper found that a male doctor was the most frequently 
identified barrier in both adequately-screened and under-screened women across rural, regional  
and remote populations.20 A study by Owen et al. reported that women with mental health issues 
also perceived a male general practitioner as a barrier to participating in cervical screening.21 This 
barrier was similarly noted by Kelaher et al. in culturally and linguistically diverse (CALD) populations, 
who reported that male health professionals negatively impacted their screening participation. The 
findings of this study stated that never-screened women are less likely to agree to screening with a 
male doctor.17 An additional study found that Thai immigrants prioritised cervical screening with a 
female general practitioner.16 Two of the four studies on CALD women reported the language barrier 
between themselves and the practitioner as a factor that preventing their screening 
participation.15,17 CALD women have an increased willingness to travel a greater distance to have 
cervical screening performed by a general practitioner that spoke their own language. These women 
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also stated that preferred the presence of an interpreter if the health professional did not speak 
their language. Never-screened women from CALD communities are more likely to identify language 
as a barrier than well-screened CALD women in Australia.17 
Knowing the general practitioner personally was included as a barrier by one study. Regularly 
screened women from urban, rural and remote regions all stated knowing the doctor on a personal 
basis was a barrier to cervical screening. This was also observed in under-screened women from 
urban and remote areas.20  
Finally, inadequate health promotion by the health professional was reported by three studies as a 
barrier to screening.13,19,23 BMT survivors were not informed by their treating physicians that they 
required cervical screening. 19 Brown et al. stated that WSW were incorrectly informed they were 
ineligible for cervical screening by their doctor. 13  
Logistical Barriers 
Logistical considerations including lack of time, distance, transport, cost and forgetting to be 
screened prevented women from participating in screening.13,15-21,23 A lack of time was reported as a 
barrier in four studies by older women18, BMT survivors19 and CALD women15,16. One study identified 
long distances from practitioner as a barrier to screening in well-screened women from rural and 
remote areas. This study also stated that in under-screened populations, distance was quoted as a 
barrier by women from urban, rural and remote areas. 20  
Issues with transport was a reported barrier for screening in two studies and it contributed to 
reduced screening participation in both CALD women and the general population.17,23 One study 
listed other logistical barriers including cost and not receiving a reminder letter.23   
Test-related Barriers 
The cervical screening test itself remains a barrier to screening participation, with six studies stating 
embarrassment or discomfort as a barrier.13-16,18,21-23 Under-screened women23, migrant women14-16 
and women with a history of mental health issues21 reported that cervical screening was 
embarrassing. Pain was also identified as a barrier by two studies.16,18 Pain or discomfort was 
reported as a barrier by older women18 and migrant women15,16.  
Previous adverse experiences were listed in two studies as a barrier to screening, by women with a 
history of sexual assault22 and women with mental health issues21. 




Only one study assessed women’s opinion of primary HPV testing and most women preferred HPV 
primary testing. Those that did not prefer HPV testing stated low perceived risk and not being 
sexually active as barriers to screening.24  
Two of the included studies assessed women’s experiences with self-collected vaginal samples for 
HPV testing.23,25 Mullins et al. stated that under-screened and never-screened women prefer self-
collection in comparison to well-screened women. Barriers to self-collection included desiring the 
general practitioner to complete the test, fear of doing it incorrectly, wishing to include it with other 
tests being performed by the doctor and concerns about the tests’ reliability and accuracy.25 Sultana 
et al. identified that 89.2% of women preferred to perform a self-collected vaginal sample at home, 
1.2% preferred to perform a self-collected vaginal sample at the clinic and 6% stated they would 
prefer a health professional to perform the test. The women who declined the self-collection 
reported they did not perform the test as they believed health professionals should complete it, 
were not sexually active and considered it to be not as reliable as a Pap test.  Women who intended 
to complete the self-collected vaginal sample reported they did not as they forgot, did not have the 
time, believed it to be uncomfortable and were afraid of the result. 23 
Participation Rates 
The age-standardised Australian screening participation rate for 2015-2016 was 56.0%.1 A lower 
screening rate was seen in older women18, BMT survivors19 and certain migrant groups17.   
DISCUSSION 
This systematic review assessed 13 papers that identified Australian women’s self-perceived barriers 
to cervical screening.  
There was a lack of consensus across the studies as to which factors significantly impeded a woman’s 
participation in cervical screening. Lack of time, embarrassment, perceived irrelevance, fear of 
results and a male provider were identified in four or more studies as barriers to screening. Study 
bias may not be the primary reason for the lack of consensus between studies, as of these studies 
three were identified as good quality and five were fair quality studies and thus heterogeneity 
between the studied sub-groups may be underlying factor. 13-16,18-21,23 Literature reviews and 
research projects completed in overseas countries also have identified these factors as barriers to 
screening.6,26 Tanner-Smith et al. identified that most barriers are due to cervical screening inducing 
negative emotions during the test itself or while awaiting results.27  
Chorley et al. deconstructed the thought process surrounding screening into two main themes, the 
positive value of screening against its perceived emotional and physical threat.6 A woman’s negative 
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association with cervical screening provides the barrier and prevents her participation in screening. 
The five studies that analysed barriers by screening status revealed that under-screened or never-
screened women are more likely to identify barriers to screening than their well-screened 
counterparts.13,17,18,20,23 For instance, Sultana et al. observed that well-screened women are less likely 
to identify lack of time as a barrier to screening (24.6%), in comparison to under-screened women 
(14.9%).23 As per the Health Belief Model, a woman’s likelihood to participate in screening is 
dependent on her perceived benefits against barriers to behaviour change.28 This suggests that well-
screened women may have greater understanding of the benefits of screening and that may 
outweigh inhibitions towards screening. Hence, well-targeted educational interventions may play a 
key role in empowering under-screened women to improve their screening behaviour.29 The 
potential of education intervention in screening rates was demonstrated by O’Brien et al. These 
researchers showed at six months after the intervention, 71% of under-screened women (p=0.004) 
participated in cervical screening in comparison to 22% of the control group (p=0.004).30 
Authors assessed three papers on HPV screening, with one assessing primary HPV testing24 and two 
on self-sampled HPV testing23,25. The small number of studies addressing Australian women’s 
attitudes to HPV testing and self-sampling exhibits the need for further research. One good quality 
study stated that HPV testing is not a barrier to screening, which is reassuring considering the new 
NCSP uses primary HPV testing.24 Two fair quality studies assessed women’s attitudes towards self-
sampled HPV testing and produced conflicting results as to whether women preferred self-sampling 
or practitioner collecting. Nevertheless, self-sampling still presents similar barriers to conventional 
cervical screening such as lack of time, discomfort and fear of results.23,25 However, the increased 
preference for self-sampling in never-screened (62.1%, p<0.001) and under-screened women 
(64.8%, p<0.001)25 could predict promising results for the use of self-sampling in these populations 
in the new NCSP. Self-sampling could potentially improve cervical screening participation rates, as a 
Swedish study showed that women were more likely to return a home self-sample HPV test (29.8%) 
than make an appointment for cervical screening after a reminder letter (26.2%).31 The primary 
appeal of the self-sample HPV test is the convenience of completing it at home (88% preference) 
rather than the medical clinic (1.2% preference).23 However, under the new NCSP eligible women are 
to complete the self-sample HPV test at the medical clinic.1 Hence, it is difficult to predict the 
success of this initiative. Also, the evaluated studies did not assess the barriers to seeking further 
medical follow-up after receiving a positive result from a self-sampled HPV test although, previous 
meta-analysis showed that self-screened women had a high compliance rate to further follow-up 




The screening participation rates in the included studies were mostly comparable to the Australian 
screening rate except in older women18, BMT survivors19 and certain migrants groups17. Self-
reported screening rates are to be interpreted with caution due to a small sample of the target 
population and the inaccuracies associated with self-reported data. Furthermore, this review 
includes papers written since 1991 where the calculated participation rates of the older studies may 
not be reflective of the current Australian population.  
Reduced screening participation in these populations may be due to their specific barriers to 
screening. Migrant women are more likely place increased importance on a bilingual health 
practitioner. This is seen in the results of Kelaher et al., as 36.4% of women stated that they would 
travel a long distance to see a general practitioner who spoke their language and 45.8% of these 
women preferred an interpreter to be present if the practitioner did not speak their language.17 
Adunlin et al. reviewed factors that prevented American immigrants from participating in breast and 
cervical screening which also echoed that limited English proficiency and lack of translation were 
barriers in these women.8 While under-screened BMT survivors reported a belief that screening was 
unnecessary (29.4%) and not being informed that they required screening by their doctor (45.6%) as 
barriers to screening.19 This is concerning due to the increased susceptibility of these 
immunosuppressed patients to cervical cancer.  
LIMITATIONS  
There were several limitations the authors faced when conducting this systematic review. Firstly, 
while all studies assessed women in the Australian population, 11 studies concentrated on sub-
groups within the populations such as migrants, older women, WSW and women with mental health 
issues.13-18,21 The varying cultural and personal beliefs in these subpopulations lead each group to 
generate unique barriers to screening and add to heterogeneity across results. In addition, none of 
the included studies assessed barriers to cervical screening in Aboriginal and Torres Strait Islander 
women, even though they are an important under-screened population in Australia.1    
There were also inconsistencies in the presentation of results, as the studies had no universal system 
to classify barriers to screening. Kelaher et al. utilised the Transtheoretical Model17 to classify 
barriers while Brown et al.13 and Fernbach15 listed barriers by the steps in the screening process. 
Girgis et al.20 only reported the top three barriers for each group and the authors were contacted for 
the full dataset, but it was unavailable. Furthermore, the breadth of barriers studied were reliant on 
author’s survey or interview design, Cheek et al.14 only assessed embarrassment and discomfort 
whereas, Sultana et al.23 analysed 16 different barriers to screening. In addition, only Cockburn et al 
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clearly stated the extent to which a barrier affected screening participation.18 In the remaining 
studies, authors had to assume that the investigated barriers were significant barriers to screening.  
Eight of the studies did not analyse their barriers by screening status. This may be due to author 
preference or underpowered studies. Particular barriers analysed by screening status reported by 
Brown et al. were not included as they were statistically insignificant.13   
The lack of sample size calculation and low participation rates provided the main sources of bias in 
the studies. All thirteen studies were cross-sectional surveys which have a higher risk of bias than 
other methodologies.33 Seven studies used convenience sampling13,17-22, two used snowball 
recruitment15,16 and four used random sampling14,23-25. Convenience sampling and snowball 
recruitment are less randomised than other sampling approaches and are subject to volunteer 
bias.33 This may result in a sample that is not wholly representative of the population under 
investigation.  
Due to the review design, only published studies were assessed by authors. Certain barriers and 
demographic sub-populations were investigated more in published studies. For example, cervical 
screening in migrant women appears to be more widely researched than other populations.14-17 The 
lack of studies available on the general Australian population could be due to null results leading to 
the study not being published or a lack of research itself. Hence, this literature review is subject to 
publication bias.   
CLINICAL IMPLICATIONS  
The reported reduction in screening participation and the introduction of the new guidelines provide 
an ideal opportunity to discuss barriers to cervical screening in Australia and highlight the timeliness 
of this review. Moreover, it is important for clinicians to understand whether the introduction of 
primary HPV testing and self-collected sampling will affect women’s screening behaviours as 
Australia transitions to the new NCSP. General practitioners should offer opportunistic patient 
education and screening for women eligible to screening and facilitate conversations with under-
screened women to overcome the barriers that prevent their participation in the NCSP. Clinicians 
should also be offered education regarding screening guidelines in specific subgroups as 9% of 
WSW13 and 45.6% of BMT survivors19 were provided incorrect information. Increased clinician 
knowledge and education interventions may lead to improved screening participation in Australian 





In the new NCSP, policymakers have acknowledged the need for targeted approaches to certain 
subpopulations such as Aboriginal and Torres Strait Islander women, immune-deficient women and 
women who have experienced sexual abuse. They have also stated the need for further research and 
the development of appropriate screening strategies in these groups.34 This systematic review has 
further identified other underscreened subpopulations that policymakers should consider when 
developing targeted screening strategies. These health interventions should also target under-
screened populations including WSW, older women and migrant groups. The creation of health 
interventions to increased cervical screening in under-screened populations are key in reducing 
cervical cancer mortality, as fifty percent of cervical cancer occurs in never screened women.34    
RESEARCH IMPLICATIONS  
This review mainly concentrated on women’s barriers to cervical screening as per the previous NCSP, 
as only three studies evaluated barriers to HPV testing.23-25 Additionally, the reviewed articles often 
concentrated on specific groups within the general Australian population and many articles reviewed 
were over ten years old and. Subsequently, authors recommend new research that investigate 
women’s barriers to cervical screening under the new NCSP, particularly primary HPV testing. As 
only 56% of eligible women participated in screening, there is a need to analyse barriers to cervical 
screening in both the general Australian population and its under-screened populations.1 
Furthermore, researchers should design and assess the efficacy of health interventions, such as 
education programs and media campaigns, to improve Australian women’s participation in the 
NCSP.  
CONCLUSION 
Australian women do not participate in cervical screening due to a variety of personal, practitioner, 
logistical and test-related barriers. The most common barriers to screening are a lack of time, 
embarrassment, fear of results, believing the test to be irrelevant and preference for a female 
provider. It may be beneficial for health professionals to develop health promotion programs and 
interventions that target these barriers to improve the cervical screening rates in Australia. 
Secondly, research into women’s attitudes towards HPV testing and self-sampling should be 
conducted considering the new cervical screening guidelines. Additional research into barriers to 
cervical screening in the general Australian population should also be conducted.  
FUNDING: Nil 
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Table 1: Study Characteristics†  
Study Study population Recruitment Participant numbers Completion rate 
Brown, 200313 WSW Convenience sampling  409  80% 
Cheek, 199914 Vietnamese migrants  Random sampling  199 29% 
Cockburn, 199218 40-70y  Convenience sampling  437 57% 
Dieng, 201324 18-70y  Random sampling  1279 81.4% 
Dyer, 201619 BMT survivors  Convenience sampling 441 76% 
Fernbach, 200215  Migrants from former Yugoslavia  Snowball recruitment  221 - 
Girgis, 199920  Rural 
Remote 
Urban 







Harsanyi, 200322 Sexual assault survivors  Convenience sampling 78 - 
Jirojwong, 200116 Thai migrants Snowball recruitment  145 96% 




South Sea Islanders 
Convenience sampling 234 - 
Mullins, 201425 18-69y Random sampling  2526 67.40% 
Owen, 200221  Acute psychiatric inpatients  Convenience sampling 100 87% 
Sultana, 201523 Never/Underscreened  Random sampling  872 25% 
† Location and study design were not included in this table as all studies were cross-sectional studies completed in Australia
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Table 2: Quality Assessment Tool. Modified from National Heart, Lung and Blood Institute Tool for 
Observational Studies.  
 Quality Assessment Point†  
Study 1 2 3 4 5 6 7‡ 8 9 10‡ 11 12‡ 13‡ 14‡ OUTCOME 
Brown 200313 Y Y Y Y N Y  Y Y  N    GOOD 
Cheek 199914 Y Y N Y N Y  N Y  N    FAIR 
Cockburn 199218 Y Y Y Y N Y  Y Y  Y    GOOD 
Dieng 201324 Y Y Y Y N Y  Y Y  N    GOOD 
Dyer 201619 Y Y Y Y N Y  N Y  N    FAIR 
Fernbach 200215  Y Y N Y N Y  N Y  N    FAIR 
Girgis 199920  Y Y Y Y N Y  Y Y  N    GOOD 
Harsanyi 200322 Y Y N Y N Y  N Y  N    FAIR 
Jirojwong 200116 Y Y Y Y N Y  N Y  N    FAIR 
Kelaher 199917 Y Y N Y N Y  Y Y  N    FAIR 
Mullins 201425 Y Y Y Y N Y  N Y  N    FAIR 
Owen 200221  Y Y Y Y N Y  N Y  N    GOOD 
Sultana 201523 Y Y N Y N Y  Y Y  N    FAIR 
  
 
†- (1) Defined research question (2) clear study population (3)[50 % participation rate (4) uniform 
inclusion and exclusion criteria (5) sample size justification (6) exposure of interest measured before 
outcome (7) sufficient time frame between exposure and outcome (8) examination of different 
levels of exposure in relation to outcome (9) defined and evenly applied exposure methods (10) 
exposure assessed more than once over time (11) defined and consistently applied outcome 
measure (12) blinding of assessors (13) loss of follow-up less than 20 % (14) key potential 
confounding variables measured and adjusted statistically for impact between exposure and 
outcome 
 




Table 3: Barriers and screening participation for cervical screening 
Study Study population Screening 
participation (%) 








Brown 200313 WSW Well-screened: 66 
Underscreened: 22 
Never-screened: 12 
Deciding to have a pap test 
Choosing a practitioner 
Making the appointment 

















Cheek 199914 Vietnamese migrants Well-screened: 75 Uncomfortable/embarrassing 
 
36-48   68  
Cockburn 199218 40-70 years old Underscreened: 41 Embarrassment 
Fear of results 
Pain 













Dyer 201619 BMT survivors  Well-screened: 47.5 
Underscreened: 52.5  
Lack of time 
Cost 
Do not require 





    
Fernbach 200215  Migrants from former 
Yugoslavia   
Well-screened: 77 Uncomfortable 
Embarrassment 
Fear of results 
Lack of time 
Do not require   
Language preference 








    


























































































Harsanyi 200322 Sexual assault 
survivors  
Well-screened: 67 Fear of test 
Previous negative experience 
  26 
35 
  
Jirojwong 200116 Thai migrants Well-screened: 44 Gender preference 
Asymptomatic 
Pain 
Unsure of benefits 
Unmarried 
Embarrassment  
Fear of result 
Fear of test 
Unsure how to organise 
Lack of time 














    




South Sea Islanders 



























Previous negative experience 
Transport  














Unsure when needed 
Not sexually active 
Embarrassment 
Pain/uncomfortable 
Previous negative experience 
Not comfortable to ask dr 
Dr has not suggested 
Lack of time 
Choosing practitioner  
Travel 
Cost 






































































Table 4: Barriers, test preference and screening participation for studies on HPV testing 
Study Study population Test type Screening 
participation (%) 
Testing preference (%) Barriers (%) 
 
Dieng 201324  18-70 years old Primary HPV test Well-screened: 66 
Underscreened: 32 
 
HPV test: 85 Low perceived risk 
Not sexually active  
18 
35 





Self-collected HPV: 34.0 
Practitioner: 57.4 
Prefer health professional 
Incorrect technique 








Sultana 201523 Never/under-screened Self-collected 
vaginal sample 
Screened <5y: 31 
Under-screened: 39 
Never-screened: 21 




Prefer health professional 
Not sexually active 
Reliability 
 
Intended to complete 
Forgot to complete 
Lack of time  
Perceived discomfort 
Fear of results  
 
17 
10 
6 
 
 
63 
21 
10 
5 
22 
 
 
